Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis.
about
Intrathecal baclofen for treating spasticity in children with cerebral palsySocietal costs of intrathecal drug delivery systems--an administrative analysis based on patient claims.Intrathecal baclofen therapy in paediatrics: a study protocol for an Australian multicentre, 10-year prospective audit.Medical cost impact of intrathecal baclofen therapy for severe spasticity.Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.Economic evaluation and cost of interventions for cerebral palsy: a systematic review.
P2860
Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Intrathecal baclofen therapy i ...... a cost-effectiveness analysis.
@en
Intrathecal baclofen therapy i ...... a cost-effectiveness analysis.
@nl
type
label
Intrathecal baclofen therapy i ...... a cost-effectiveness analysis.
@en
Intrathecal baclofen therapy i ...... a cost-effectiveness analysis.
@nl
prefLabel
Intrathecal baclofen therapy i ...... a cost-effectiveness analysis.
@en
Intrathecal baclofen therapy i ...... a cost-effectiveness analysis.
@nl
P2093
P1476
Intrathecal baclofen therapy i ...... a cost-effectiveness analysis.
@en
P2093
A J H A Ament
Dutch Study Group on Child Spasticity
E P M van Raak
J S H Vles
M A Hoving
S M A A Evers
P304
P356
10.1111/J.1469-8749.2008.02059.X
P577
2008-04-14T00:00:00Z